Viatris Slovakia S.R.O. (Slovakia)

Viatris Slovakia s. r. o. is the Slovak subsidiary of Viatris, a global pharmaceutical company formed through the combination of Mylan and the Upjohn division of Pfizer. Based in Bratislava, Viatris Slovakia focuses on the marketing, distribution and regulatory support of a broad portfolio of medicinal products on the Slovak market. Its product range includes prescription medicines, generic pharmaceuticals, biosimilar products and selected over the counter medicines across multiple therapeutic areas, as reflected in national drug databases and professional platforms. The company maintains specialised channels and information services for healthcare professionals and pharmacists, including product information, safety reporting contacts and medical information services. Viatris Slovakia operates under a quality and compliance framework aligned with European and Slovak pharmaceutical regulations and Good Distribution Practice standards, working closely with wholesalers, pharmacies, hospitals and healthcare institutions. Geographically, the company serves the Slovak market while being integrated into Viatris global commercial infrastructure and supply chain covering North America, Europe, Asia Pacific and emerging markets. Strategic focus is on ensuring patient access to a wide spectrum of high quality, affordable and innovative medicines, strengthening relationships with healthcare stakeholders and leveraging the global Viatris portfolio and development pipeline in the Slovak healthcare system.